Skip to content

Longevity Families of the Netherlands

Longevity Families of the Netherlands

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06374069
Acronym
LOF-NL
Enrollment
600
Registered
2024-04-18
Start date
2023-09-11
Completion date
2026-12-01
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Extreme Longevity, Familial Longevity, Longevity

Brief summary

The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity. The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.

Interventions

None listed

Sponsors

Leiden University Medical Center
Lead SponsorOTHER
Jacobijn Gussekloo, Prof. dr.
CollaboratorUNKNOWN
Simon P. Mooijaart, Prof. dr.
CollaboratorUNKNOWN

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity * Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Identifying the genetic variants of Familial Longevitythrough study completion, an average of 2 yearsTo identify gene variants associated with healthy aging and protection from (multi)morbidity

Secondary

MeasureTime frameDescription
Studying the environmental factor of Familial Longevity through questionnaires and its interaction with the genetic componentthrough study completion, an average of 2 yearsTo study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026